## MELI: MercadoLibre, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.99 indicates fundamental undervaluation. Quality metrics strong (ROE 41%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($1865.97)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. China Universal Asset Management Co. Ltd. Purchases 739 Shares of MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251214T102841 | Neutral | Relevance: 100%
- China Universal Asset Management Co. Ltd. significantly increased its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 59.0%, adding 739 shares to hold a total of 1,991 shares valued at $5.204 million. Despite MercadoLibre missing its EPS expectations, analysts maintain a "Moderate Buy" rating with a consensus price target of $2,848.82. The company, which has a market cap of $102.21 billion, reported a 39.5% year-over-year revenue increase.

**2. MercadoLibre Stock (NASDAQ: MELI) News on Dec. 12, 2025: Humanoid Robots, New Bonds, and a High-Stakes 2026 Outlook**
- Source: ts2.tech | 20251212T190858 | Neutral | Relevance: 100%
- MercadoLibre (MELI) is navigating a complex landscape marked by rapid growth, heavy investment in market share, and stiff competition. The company is deploying humanoid robots for fulfillment, issued $750 million in senior unsecured notes, and faces ongoing pressure on margins due to aggressive spending in Brazil and Mexico. Despite analyst optimism, the market is closely watching for MELI to demonstrate a credible path back to higher margins amidst competitive and regulatory challenges as it heads into 2026.

**3. MercadoLibre (MELI) Stock Is Up, What You Need To Know**
- Source: Finviz | 20251211T200925 | Bullish | Relevance: 100%
- MercadoLibre (MELI) stock rose 2.7% after the company announced a commercial agreement with Agility Robotics to deploy humanoid robots in its San Antonio, Texas facility for commerce fulfillment. This partnership aims to explore the use of AI-powered humanoids to enhance logistics operations across Mercado Libre's Latin American warehouses. The company previously reported record sales volumes during El Buen Fin, processing over 3,000 purchases per minute, with its payment division expanding credit lines to boost sales.

**4. 1,236 Shares in MercadoLibre, Inc. $MELI Bought by Caxton Associates LLP**
- Source: MarketBeat | 20251215T090937 | Neutral | Relevance: 100%
- Caxton Associates LLP recently acquired 1,236 shares of MercadoLibre, Inc. (NASDAQ:MELI) valued at approximately $3.23 million in Q2, contributing to the 87.62% institutional ownership of the company. Despite missing EPS estimates, MercadoLibre saw a 39.5% year-over-year revenue increase, surpassing expectations. The stock currently trades around $2,015.89, with analysts holding a "Moderate Buy" consensus and an average price target of $2,848.82.

**5. MASTERINVEST Kapitalanlage GmbH Purchases Shares of 1,231 MercadoLibre, Inc. $MELI**
- Source: MarketBeat | 20251214T150937 | Somewhat-Bullish | Relevance: 100%
- MASTERINVEST Kapitalanlage GmbH recently acquired 1,231 shares of MercadoLibre, Inc. (NASDAQ:MELI) valued at approximately $3.217 million in the second quarter. This move comes as MercadoLibre reported mixed quarterly results, with EPS missing estimates but revenue exceeding expectations and showing significant year-over-year growth. Analysts currently rate MercadoLibre as a "Moderate Buy" with a consensus target price of $2,848.82.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | BTIG | $2750 | $2750 | 0% |
| 2025-11-24 | UBS | $2900 | $3000 | -3% |
| 2025-11-14 | BTIG | $2750 | $2750 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | BTIG | reit | Buy |
| 2025-11-24 | UBS | main | Buy |
| 2025-11-14 | BTIG | reit | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- JPMORGAN CHASE & CO: 7.0% (+78.3%)
- BAILLIE GIFFORD & CO: 6.5% (-5.4%)
- Morgan Stanley: 3.9% (+0.3%)
- Capital Research Glo: 3.6% (+3.4%)
- Capital World Invest: 3.4% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 11.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Forward P/E 33.3x attractive for 50% earnings growth. Quality metrics strong (ROE 41%). Balance sheet: $2.5B free cash flow. Revenue growth strong at 29% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $102.2B |
| Beta | 1.43 |
| 52W Range | $1646.00 - $2645.22 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 33.3 |
| Current P/E | 50.0 |
| YoY Growth | 50.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.6% to -1.9% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. Underperforming sector by 4.9pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram positive (0.52), confirming momentum. RSI neutral at 44. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.88% (CS: 23) | Neutral |
| RSI_14 | 43.5 | Neutral |
| MACD Histogram | 0.52 | Bullish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 0.949x | Below |
| vs SMA200 | 0.888x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $2015.89
- **Stop Loss:** $1865.97 (7.4% risk)
- **Target:** $2315.73 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 8
- **Position Value:** $16,127.12
- **Portfolio %:** 16.13%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-24 (Est: $11.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.30 | $8.32 | -10.5% |
| 2025Q2 | $11.89 | $10.31 | -13.3% |
| 2025Q1 | $8.27 | $9.74 | +17.8% |
| 2024Q4 | $7.56 | $12.61 | +66.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*